Welcome to the e-CCO Library!

N20: Experience with therapeutic drug monitoring on adalimumab in paediatric inflammatory bowel disease (pIBD)
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

S. Sider*1, L. Cococcioni1, A. ElZein1, S. Chadokufa1, R. Buckingham1, N. Shah1, A. Ocholi1, O. Borrelli1, F. Kiparissi1

Created: Friday, 22 February 2019, 9:41 AM
Files: 1
N20: Safety of extended blood monitoring for adult Inflammatory Bowel Disease (IBD) patients on oral azathioprine during the COVID-19 pandemic: a single-centre audit
Year: 2022
Source: ECCO'22
Authors: AL-HASANI, A.(1);Younge, L.(1);Chana, A.(1);
Created: Friday, 11 February 2022, 3:52 PM
N20: The added shame of IBD: experiences of people from various ethnic backgrounds discussing sexual wellbeing in clinical settings.
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Fourie, S.(1)*;Czuber-Dochan, W.(2);Norton, C.(2);
Created: Friday, 14 July 2023, 10:43 AM
N20: Transcutaneous Electrical Acupuncture-point Stimulation for Depressive symptoms in Inflammatory Bowel Disease: a feasibility study
Year: 2025
Source: ECCO'25
Authors: Nortonx7x7x7 C.(1)*;Huangx7x7x7 C.(2);Czuber-Dochanx7x7x7 W.(2);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
N21 Self-management and healthcare utilisation of 16–21 year olds with inflammatory bowel disease (IBD) attending one Irish hospital
Year: 2020
Source:

ECCO'20 Vienna

Authors:

M. Forry, M. Milewska, C. Lardner, T. Lukose, N. Godwin, K. Boland, S. Patchett, A. O’Toole

Created: Thursday, 30 January 2020, 10:12 AM
N21: Clinical Nurse Specialist in Inflammatory Bowel Disease (CNS-IBD). Care challenges and economic sustainability. A Scoping review.
Year: 2025
Source: ECCO'25
Authors: Mozos Muñozx7x7x7 C.(1);Lavín Expósitox7x7x7 C.(1)*;Bouhmidi Assa Kalix7x7x7 A.(1);Jurado Monroyx7x7x7 R.M.(1);Pinilla Sánchezx7x7x7 J.(1);Bonillo Merinox7x7x7 C.(1);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
N21: Patient education is (sometimes) better than cure.
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Müskens, B.(1)*;
Created: Friday, 14 July 2023, 10:43 AM
N21: The interpretation of thiopurine metabolites in clinical practice: IBD nurses experience in three North West England NHS trusts
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

R. Campbell*1, E. Nelson2, S. Kari2, J. Hocking3, T. Hickey3

Created: Friday, 22 February 2019, 9:41 AM
Files: 1
N22 Nurse led therapeutic drug monitoring (TDM) of Infliximab in IBD
Year: 2020
Source:

ECCO'20 Vienna

Authors:

S. Gleeson1, K. Sugrue2, M. Buckley2, J. McCarthy2

Created: Thursday, 30 January 2020, 10:12 AM
N22: Audit into initial response to vedolizumab infusions for IBD
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

G. Lloyd-Ford*1, M. Gordon1

Created: Friday, 22 February 2019, 9:41 AM
N22: Exploring the Competencies of IBD Nurses in Italy: A Cross-sectional Survey
Year: 2025
Source: ECCO'25
Authors: Schiavonix7x7x7 E.(1);Grecox7x7x7 D.(2);Scaldaferrix7x7x7 F.(1);Napolitanox7x7x7 D.(1)*;
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
N22: Inflammatory bowel disease nursing in Italy: the experience of the Academic Hospital of Udine.
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Povoli, A.(1);Simonetta, G.(1);D'Agaro, P.(1);Marangone, S.(1);Marino, M.(1)*;Berretti, D.(1);
Created: Friday, 14 July 2023, 10:43 AM
N23 Concerns of patients with inflammatory bowel disease in the process of disease management
Year: 2020
Source:

ECCO'20 Vienna

Authors:

S.M. Mohsenizadeh1, Z.S. Manzari2, H. vosoghinia3, H. Ebrahimipour4

Created: Thursday, 30 January 2020, 10:12 AM
N23: Burnout among European IBD specialists – a survey supported by ECCO
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Sánta, A.(1)*;Volosin, M.(2);Farkas, K.(1);Keresztes, C.(3);Rafael , B.(4);Molnár, T.(1);
Created: Friday, 14 July 2023, 10:43 AM
N23: IBD patients experience of the care given at the Stockholm Gastro Centre
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

S. Jäghult*1,2, S. Soto Villagran2, S. Pengel2, L. Niculae2

Created: Friday, 22 February 2019, 9:41 AM
Files: 1
N23: Volume and Impact of Text Communications with an IBD Nurse– A Large Tertiary Center Experience
Year: 2025
Source: ECCO'25
Authors: Haj Natourx7x7x7 O.(1)*; Talan Asherx7x7x7 A.(2); Levartovskyx7x7x7 A.(2);Goshenx7x7x7 G.(3);Gorenx7x7x7 M.(2); Ben-Yehudax7x7x7 Y.(3);Kopylovx7x7x7 U.(4); Ben-Horinx7x7x7 S.(2);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
N24 Prioritised adolescent healthcare transition readiness factors by Canadian inflammatory bowel disease nurses
Year: 2020
Source:

ECCO'20 Vienna

Authors:

N. Rohatinsky1, T. Risling1, M. Kumaran2, L.A. Hellsten3

Created: Thursday, 30 January 2020, 10:12 AM
N24: A longitudinal qualitative exploration of symptom clusters in newly diagnosed patients with Crohn’s disease
Year: 2025
Source: ECCO'25
Authors: Chenx7x7x7 L.(1)*;Zhoux7x7x7 Y.(2);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
N24: At Home Calprotectin a United Kingdom Patient Perspectives and Tertiary Center Experience
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Avery, P.(1)*;Adio, J.(1);Cornford, R.(2);Younge, L.(1);
Created: Friday, 14 July 2023, 10:43 AM
N24: Experience with Ustekinumab (STELARA®) in Paediatric inflammatory bowel disease (pIBD) – A case series
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

R. Buckingham*1, S. Sider1, L. Cococcioni1, A. ElZein1, S. Chadokufa1, N. Shah1, A. Ocholi1, O. Borrelli1, F. Kiparissi1

Created: Friday, 22 February 2019, 9:41 AM
Files: 1